Public Support and Ethical Debate on Gene-Edited Humans
Since the emergence of Crispr-Cas9 gene-editing technology in the early 2010s, ethical concerns surrounding genetically modified humans, often referred to as designer babies, have intensified. Currently, a global legal ban exists on human germline editing—genetic modifications to embryos that can be inherited by future generations—with no country, including the UK, permitting it. However, recent scientific advancements and polling data indicate that both scientists and the public consider gene-edited humans to be a likely and even desirable development in the near future.
Advances in Base Editing and Scientific Perspectives
Two recent studies have employed base editing, a more precise next-generation Crispr technique, on human embryos to investigate early development and disease mechanisms. This type of research is legally permitted in the UK and US, provided the embryos are destroyed within 14 days. Dieter Egli, the lead author of one study, emphasized that the technology is not yet ready for clinical application but that these advances will
"guide responsible research to achieve its ultimate safe and effective use". This perspective aligns with many scientists who foresee the regulated use of germline editing to eliminate hereditary diseases as inevitable, with safety concerns being the primary objection.
Legal and Ethical Considerations Beyond Safety
Most existing laws against gene editing focus on safety rather than broader ethical issues, rendering these laws less absolute than they might seem. The Nuffield Council on Bioethics holds that human germline editing is not inherently ethically unacceptable, a stance shared by the US National Academies of Sciences, Engineering, and Medicine. Bioethicist R Alta Charo notes that
"each new technological advance chips away at objections over safety, forcing us toward more fundamental questions on whether this technology should be used at all, and if so in what situations."Therefore, any legal revisions must address these fundamental ethical questions and specific applications, rather than narrowly focusing on safety alone.
Public Opinion and Trust in Science
Public sentiment appears to be advancing ahead of scientific consensus. A poll conducted by Ipsos for the Progress Educational Trust revealed that a majority of respondents in the UK, Spain, and the Netherlands support gene editing to correct life-threatening genetic conditions such as cystic fibrosis. Additionally, a plurality of respondents in these countries, as well as in Italy, support its use for challenging but manageable conditions like asthma. Considering that IVF research was controversial through the 1980s, this indicates a significant level of public trust in science and a growing acceptance of manipulating human genetics.
Risks of Designer Babies and Regulatory Challenges
Despite this support, human germline editing should not be considered inevitable. Certain genetic conditions cannot be addressed through existing methods like embryo selection, and if deemed safe, gene editing should initially be reserved for these rare cases. The concept of designer babies is not merely hypothetical; in regions such as the UK, where donor selection is prohibited in IVF, some couples already seek to screen for preferred traits. Alarmingly, in the US, collaborations have emerged between IVF companies and laboratories conducting base-editing research, highlighting the proximity of medical treatments to on-demand genetic customization. Discussions must acknowledge that while regulation can restrict these ethically questionable uses, it is unlikely to eradicate them entirely.
Future Directions and the Need for Open Dialogue
For now, human germline editing should remain banned primarily due to safety concerns. However, this rationale may not be sustainable indefinitely, and reliance on safety as the sole argument is insufficient. It is imperative to initiate comprehensive conversations about the future trajectory of this technology and the ethical frameworks that should govern its application.
